Lupus

Risk of poor pregnancy outcomes in lupus patients continues to remain high, especially in the setting of high disease activity. Significant racial and ethnic disparities are also described in this…

There has been an explosion of trials in SLE, including nonrenal and glomerulonephritis studies. Importantly, several drug approvals in lupus have occurred recently: belimumab (high dose) for lupus…

The pharmacology treatment in systemic lupus erythematosus (SLE) is a rapidly expanding field of research that provides excitement and optimism to both the patients and the clinicians. As we have…